CM
CM Management Portfolio holdings
AUM
$110M
1-Year Est. Return
9.76%
1 Year Est. Return
+9.76%
AUM
$110M
AUM Growth
+$10.3M
(+10%)
Holding
76
Top Buys
| 1 | +$2.01M | |
| 2 | +$1.89M | |
| 3 | +$1.16M | |
| 4 |
Warner Bros
WBD
|
+$1.15M |
| 5 |
Pfizer
PFE
|
+$1.09M |
Top Sells
| 1 | +$2.65M | |
| 2 | +$2.48M | |
| 3 | +$1.61M | |
| 4 |
Cohu
COHU
|
+$1.54M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
+$1.25M |
Sector Composition
| 1 | Healthcare | 31.09% |
| 2 | Technology | 10.92% |
| 3 | Materials | 10.24% |
| 4 | Financials | 10.01% |
| 5 | Industrials | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alico
ALCO
$266M
| $7.35M | 6.7% |
225,000
|
|
||
|
TGB
2
Taseko Mines
TGB
$1.29B
| $7.25M | 6.6% |
2,300,000
-150,000
|
|
||
3
Rigel Pharmaceuticals
RIGL
$504M
| $4.68M | 4.26% |
250,000
|
|
||
4
Radiant Logistics
RLGT
$286M
| $4.56M | 4.15% |
750,000
-25,000
|
|
||
5
Preformed Line Products
PLPC
$1.12B
| $4.47M | 4.08% |
28,000
|
|
||
6
BGC Group
BGC
$4.3B
| $3.58M | 3.26% |
350,000
+50,000
|
|
||
7
Newmark Group
NMRK
$3.18B
| $3.34M | 3.04% |
275,000
|
|
||
8
inTEST
INTT
$104M
| $3.06M | 2.79% |
420,594
+45,594
|
|
||
|
9
Warner Bros
WBD
$45.3B
| $2.87M | 2.61% |
250,000
+100,000
|
|
||
10
Amicus Therapeutics
FOLD
$2.5B
| $2.58M | 2.35% |
450,000
|
|
||
11
Talos Energy
TALO
$1.59B
| $2.54M | 2.32% |
300,000
-50,000
|
|
||
12
Sabre
SABR
$706M
| $2.53M | 2.3% |
800,000
+100,000
|
|
||
13
ClearPoint Neuro
CLPT
$719M
| $2.39M | 2.17% |
200,000
+25,000
|
|
||
14
Republic Bancorp
RBCAA
$1.34B
| $2.34M | 2.13% |
32,000
-3,000
|
|
||
15
ARKO Corp
ARKO
$450M
| $2.33M | 2.12% |
700,000
-350,000
|
|
||
16
Park Hotels & Resorts
PK
$2.18B
| $2.3M | 2.1% |
225,000
+25,000
|
|
||
17
Viatris
VTRS
$11.8B
| $2.23M | 2.03% |
250,000
+25,000
|
|
||
18
Organon & Co
OGN
$2.44B
| $2.18M | 1.98% |
225,000
+75,000
|
|
||
19
MarineMax
HZO
$557M
| $2.01M | 1.83% |
+80,000
|
|
||
|
CGAU
20
Centerra Gold
CGAU
$2.58B
| $1.98M | 1.81% |
275,000
-75,000
|
|
||
|
BRKL
21
DELISTED
Brookline Bancorp
BRKL
| $1.9M | 1.73% |
180,000
|
|
||
22
IQVIA
IQV
$35B
| $1.89M | 1.72% |
+12,000
|
|
||
23
Ark Restaurants
ARKR
$25.8M
| $1.8M | 1.64% |
200,000
|
|
||
24
Atea Pharmaceuticals
AVIR
$248M
| $1.8M | 1.64% |
500,000
|
|
||
25
Coherus Oncology
CHRS
$199M
| $1.65M | 1.5% |
2,250,000
+102,500
|
|